Nascent Biotech Investigation Drug Product, Pritumumab, to be Studied as a Potential Therapeutic agent against (Coronavirus) Covid-19
March 3, 2020 San Diego, CA USA. – Nascent Biotech, Inc. (OTCQB: NBIO), today announced its intention to begin research on a possible treatment for patients infected with the Coronavirus. [...]
